Company Summary
Westlake Pharmaceuticals
Enabled by the research capabilities of Westlake University, we are a talent-led, innovation-driven biopharmaceutical company specializing in novel drugs.
The company's founders are led by world-renowned cell biologist and Dean of Westlake University’s School of Life Sciences Professor Yu Hongtao; with Professors Hu Qi and Huang Jing, also of the School of Life Sciences. This team has coupled deep expertise of their own field with inter-disciplinary technical solutions spanning cell biology, structural biology, medicinal chemistry, and artificial intelligence, to create a synergistic innovation system (from target screening to structural analysis, molecular design, drug synthesis, formulation optimization, and function validation), aiming to develop novel drug solutions to some of the most serious diseases.
Our Mission
Sharing the benefits of innovation with more patients
Our Values
Laser focus on patient health
Ambitious vision with attention to detail
Open and cross-disciplinary approach
Innovation together, with seamless collaboration
September 2020
Born in Yunqi Cloud Town, Hangzhou
December 2020
Angel funding completed
September 2022
Our first novel drug approved by NMPA, advancing into clinical research
November 2022
Pre-A round funding completed
Company awards
Self-renewal driving innovation
